Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1385&sort=-funder_divisions
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=-funder_divisions", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1421&sort=-funder_divisions", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1386&sort=-funder_divisions", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1384&sort=-funder_divisions" }, "data": [ { "type": "Grant", "id": "8701", "attributes": { "award_id": "1U01CE003367-01", "title": "Estimating the impact of SNAP, WIC, and UI in the primary prevention of multiple forms of family violence: a causal and computational approach", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 24482, "first_name": "Maria Susana", "last_name": "Panero", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-09-30", "end_date": "2024-09-29", "award_amount": 350000, "principal_investigator": { "id": 24483, "first_name": "Derek Scott", "last_name": "Brown", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 827, "ror": "", "name": "WASHINGTON UNIVERSITY", "address": "", "city": "", "state": "MO", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 827, "ror": "", "name": "WASHINGTON UNIVERSITY", "address": "", "city": "", "state": "MO", "zip": "", "country": "United States", "approved": true }, "abstract": "Child and family violence are prevalent, costly, and serious public health problems which have been linked to household economic stress, which has also been greatly increased during the Covid-19 pandemic. Supporting household income and reducing food insecurity during periods of under- or unemployment (including the pandemic) may prevent multiple forms of family violence, improving the health, safety, and well-being of children and women. The objective of the proposed research is to rigorously evaluate the impacts of three large, yet under-studied economic assistance programs—the Supplemental Nutrition Assistance Program (SNAP), Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and Unemployment Insurance (UI)— on the primary prevention of child abuse and neglect (CAN) and intimate partner violence (IPV) during the 2001- 2020 period. Each of these programs has seen significant changes and emergency adjustments during the Covid-19 pandemic, making it critical for public health policy to understand what impacts these programs have on child and family violence and economic stability. Although these programs are not designed as violence prevention tools, theoretical and empirical research clearly indicates that economic supports have the potential to meaningfully impact child and family violence. We will analyze these programs in context of the broader safety net (e.g., Medicaid expansion, state EITC) to study heterogeneous and interactions effects of policies within and across states. Using robust methods, multiple novel data sources, and outstanding institutional resources, our multidisciplinary team will rigorously evaluate the impacts of the SNAP, WIC, and UI programs as primary prevention for IPV and CAN through three interrelated aims: 1) Measure how access to SNAP and WIC and benefit generosity impacts child abuse and neglect and intimate partner violence in the pre-COVID and COVID-eras. 2) Determine whether COVID-era revisions to the UI program that improved access and generosity provided additional protections to women and children, relative to the pre-COVID era. 3) Provide key contextual data for implementation of policy impacts found in Aims 2 and 3 by assessing the responsiveness of the broader safety net as a tool for primary prevention of violence against women and children. Findings from the proposed research will advance the scientific literature on SNAP, WIC, UI, and safety net programs as potential tools for the primary prevention of child abuse and neglect, and intimate partner violence. We will disseminate accessible, evidence-based scientific findings for a variety of general and research audiences through policy briefs, social media, conference presentations, and peer-reviewed journal publications. The national reach and state variation of these programs creates a key potential opportunity to improve violence prevention, health equity, and well-being. By increasing our understanding of existing programs, this research will help scientists and the public health community to learn more about how economic policy interacts with health and social outcomes.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8703", "attributes": { "award_id": "1R21OH012175-01", "title": "Physicians? Occupational Health During Covid-19: A Qualitative Analysis of Systems Factors", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 24486, "first_name": "Maria", "last_name": "Lioce", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-09-01", "end_date": "2023-08-31", "award_amount": 201444, "principal_investigator": { "id": 24487, "first_name": "Mara Helene", "last_name": "Buchbinder", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 817, "ror": "", "name": "UNIV OF NORTH CAROLINA CHAPEL HILL", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 817, "ror": "", "name": "UNIV OF NORTH CAROLINA CHAPEL HILL", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true }, "abstract": "US physicians are at high risk for depression, substance abuse, suicide, overwork, exhaustion, and burnout. New working conditions imposed by the COVID-19 pandemic have exacerbated these occupational health burdens for physicians at a time when baseline levels of stress, burnout, and poor mental health were already overwhelmingly high. Research on physician burnout has expanded, yet much of it focuses on individual-level causes and solutions that do little to identify and respond to the broader structural factors shaping physicians' wellbeing. This study will apply an occupational health lens to examine the experiences of hospital physicians in New York City (NYC) and Seattle, the two epicenters of the US COVID-19 outbreak. Our socio- ecological model acknowledges the synergistic relationships between health systems, work environments, and individual wellbeing, and accounts for the complex interplay between the multi-level factors shaping physicians' occupational health. We will conduct qualitative interviews with physicians in NYC (n=40) and Seattle (n=40) who work at the front lines of COVID-19 care (i.e. hospital-based attending physicians or fellows practicing in internal medicine, family medicine, emergency medicine, infectious diseases, and pulmonary/critical care). By sampling physicians from diverse hospitals in each city, we will assess how differences in state and local public health responses and institutional factors mediate the way physicians respond to the crisis. Our specific aims are to: Aim 1: Describe the relationships among the systems-, professional-, and institutional-level factors shaping workplace conditions during the COVID-19 pandemic and physicians' perceptions of occupational health and wellbeing; Aim 2: Identify systems-, professional-, institutional-, and individual-level characteristics that protect physicians' occupational health and wellbeing during the COVID-19 pandemic; Aim 3. Develop and disseminate evidence-based recommendations to protect physicians' occupational health and wellbeing during normal and crisis conditions, with expert panel input. The study addresses a well-documented occupational health problem that has taken on new urgency due to the pandemic, and does so through novel attention to structural factors that shape occupational wellbeing during a unique historical moment. The outputs of this study include evidence-based recommendation to improve physicians' occupational health and wellbeing and organizational responses to pandemic conditions. Therefore, the study responds to NIOSH's Total Worker Health™ Initiative and meets NIOSH Research to Practice standards.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8707", "attributes": { "award_id": "6R03OH012215-01M002", "title": "COVID-19 Exposure, Response, Physical and Mental Health Sequelae among Nurses in New York State", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 24486, "first_name": "Maria", "last_name": "Lioce", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-09-01", "end_date": "2023-08-30", "award_amount": 80724, "principal_investigator": { "id": 24491, "first_name": "Marlene", "last_name": "Camacho", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 815, "ror": "https://ror.org/0041qmd21", "name": "SUNY Downstate Medical Center", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 815, "ror": "https://ror.org/0041qmd21", "name": "SUNY Downstate Medical Center", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": null, "keywords": [], "approved": true } }, { "type": "Grant", "id": "8708", "attributes": { "award_id": "1R03OH012215-01", "title": "COVID-19 Exposure, Response, Physical and Mental Health Sequelae among Nurses in New York State", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 24486, "first_name": "Maria", "last_name": "Lioce", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-09-01", "end_date": "2023-08-30", "award_amount": 80724, "principal_investigator": { "id": 24491, "first_name": "Marlene", "last_name": "Camacho", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 815, "ror": "https://ror.org/0041qmd21", "name": "SUNY Downstate Medical Center", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 815, "ror": "https://ror.org/0041qmd21", "name": "SUNY Downstate Medical Center", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": "Title: COVID-19 Exposure, Response, Physical and Mental Health Sequalae among Nurses in New York State Project Summary Since the declaration of the COVID-19 pandemic, there have been over 7.6 million COVID-19 cases and over 214,000 deaths in the United States (US). Simultaneously, the physical and mental health impacts of health care workers managing the COVID-19 pandemic (frontline workers) has been increasingly documented, and include increased rates of depression, anxiety, post-traumatic stress disorder, and COVID-19 infection. Associations between individual-level and organizational-level characteristics on risk of COVID-19 infection and mental health outcomes, however, are under explored among frontline nurses. To address these gaps, this project will 1) evaluate the associations between COVID-19 related burnout, coping strategies, on mental health symptoms 2) examine the impact of organizational-level factors on report of COVID-19 symptoms and diagnosis and 3) identify how individual and organizational-level protective factors may buffer adverse mental health outcomes. To accomplish these aims, we will leverage our significant expertise in COVID-19 and occupation health disease disparities research, community-engaged and mixed-method approaches, and our partnership with the PEF Union at the University Hospital of Brooklyn, to recruit 2,000 frontline nurses in New York State to complete a cross-sectional online survey, as well as in-depth qualitative interviews in a subset (N=100) to provide a mixed method dataset of COVID-19 exposures and impacts among a COVID-19 vulnerable occupational group. In this proposed project, we seek to address several key needs as identified by nurses through our union partnerships, including nurse-specific data on inadequate access and training on PPE use, mental health impacts (depression, anxiety, post-traumatic stress disorder), quantitative and qualitative data on how nurses are coping during the COVID-19 pandemic period. Through our study, we will address the NORA “Healthcare and Social Assistance” sector (62) and the “Healthy Work Design and Well-Being Program” cross-sector. Further, these research questions will be examined within the context of the New York State nursing workforce, which was the early epicenter of the US COVID-19 pandemic and currently has the 4th highest number of COVID-19 cases and the highest number of COVID-19 deaths. Findings from this study will contribute to the development of multilevel organizational strategies to support frontline workers by elucidating factors associated with COVID-19 stress and physical and mental health and identifying modifiable factors to improve well-being among vulnerable occupational groups.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8709", "attributes": { "award_id": "1R43IP001168-01A1", "title": "Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2021-09-30", "end_date": "2022-09-29", "award_amount": 243000, "principal_investigator": { "id": 24492, "first_name": "DAVID", "last_name": "CAMERINI", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1738, "ror": "", "name": "IMMPORT THERAPEUTICS, INC.", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1738, "ror": "", "name": "IMMPORT THERAPEUTICS, INC.", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true }, "abstract": "Identification of Serodiagnostic Epitopes for SARS-CoV-2, Endemic Human Coronaviruses and Influenza Virus A novel human coronavirus, which causes severe acute respiratory disease, now known as SARS- CoV-2 emerged in December 2019. Infection with SARS-CoV-2 spread rapidly worldwide and on 11 March 2020 it was declared a pandemic by the World Health Organization. As of 4 September 2020, there are over 26 million confirmed cases of coronavirus infectious disease (COVID-19) caused by this new virus, resulting in more than 870,000 deaths, corresponding to a mortality rate of ~3.3%, although the mortality rate varies widely from country to country and is subject to considerable uncertainty. Best current estimates indicate that SARS-CoV-2 has a basic reproductive number, R0, of 2 to 2.5 and an incubation time of approximately 4.6 days, which allow rapid spread of SARS-CoV-2. The USA has more cases of COVID-19 and more deaths from the disease than any other country. Since the beginning of this pandemic the scientific community came together in an unparalleled effort to advance diagnostic and vaccine development and despite all this effort and some of the success is it has brought we are still nowhere near the end of this pandemic. Although laboratory tests for the SARS-CoV-2 genome and antibodies have been developed, a reliable point-of care (POC) test for antibodies to SARS-CoV-2 and influenza virus that does not cross-react with endemic human coronaviruses (HCoV’s) is still urgently needed to guide clinical care as well as public health measures including opening schools, businesses and public gatherings. Given the impending influenza season it will be critical to have fast and specific test to distinguish between those three causes of respiratory infection with partially overlapping symptoms. We therefore seek an R43 grant to create a large protein and peptide microarray for identification of the best antigens and epitopes for sensitive and specific detection of serum antibodies reactive with SARS-CoV-2 and influenza virus. Next, we will create a sensitive and specific ELISA for antibodies to SARS-CoV-2 and will collaborate with others to create a rapid antibody assay suitable for use at the point of care. This will greatly facilitate public health and medical responses to the ongoing outbreak of COVID-19, seasonal influenza and for future waves of disease which may occur. We propose a novel approach to discovery of the best antigens or epitopes for sensitive and specific detection of infection by SARS-CoV-2 and influenza virus and for distinguishing antibodies to SARS-CoV-2 from antibodies to endemic HCoV’s. Our specific aims are: 1) add the major structural proteins of currently circulating influenza viruses, HCoV-229E and HCoV- HKU1, as well as peptides and fragments of these proteins to our existing coronavirus protein microarray, (2) develop and validate a diagnostic algorithm for distinguishing SARS-CoV-2 from infection by the four endemic HCoV’s and for detecting new influenza virus infection and (3) create and test prototype antibody ELISA’s for sensitive and specific detection of antibodies to SARS-CoV-2.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8712", "attributes": { "award_id": "1R43IP001164-01", "title": "Adjuvanted Recombinant Candidates to Prime / Boost COVID-19 RNA Vaccines", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2021-09-30", "end_date": "2022-09-29", "award_amount": 243000, "principal_investigator": { "id": 24497, "first_name": "DARRICK Albert", "last_name": "CARTER", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1739, "ror": "", "name": "PAI LIFE SCIENCES, INC.", "address": "", "city": "", "state": "WA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1739, "ror": "", "name": "PAI LIFE SCIENCES, INC.", "address": "", "city": "", "state": "WA", "zip": "", "country": "United States", "approved": true }, "abstract": "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in late 2019 causing Coronavirus Disease 2019 (COVID-19) and within months became a worldwide pandemic - as of the writing of this proposal, at least 82.5M people have been infected and more than 1.8M have died in addition to having a significant impact on the worldwide economy. Multiple vaccines are in development for COVID-19 and two of these have been awarded emergency use approval from the US FDA based on RNA platforms. With our partners at HDT Bio Corp. we are soon to enter phase I clinical trials with an RNA-based vaccine, HDT-301. While the development and deployment of these vaccines is exciting and has moved with unprecedented speed, it is unclear how durable the immune responses will be and whether or not they will induce broad protection against emerging strains. Therefore, the ability to boost these vaccines should be investigated to determine if a prime / boost regimen can be deployed in the face of waning immunity or newly emerging viral variants like the recently identified UK strain. As next generation candidates we are now producing 4 different adjuvants containing a non-GLA based TLR4 active ingredient derived from MPL referred to as 3D(6acyl)-PHAD (“3D-PHAD”). These adjuvants are called AlT4™, EmT4™, LiT4™, and MiT4. In this proposal, we will test each of these adjuvants in combination with recombinant Covid-19 spike protein in mice as adjuvanted protein vaccines and as RNA vaccine boosters. Following immunization with protein / adjuvant, potential protection against multiple Covid-19 spike protein variants will be confirmed using both ELISA and viral neutralization assays. Lead combinations will then be tested using a prime-boost strategy using a proprietary mRNA prime vaccination with HDT-301 followed by a adjuvanted protein boost. Specifically, we propose to (1) Down-select a lead adjuvant in mice and (2) Determine protection from Covid-19 using an RNA prime protein boost immunization strategy. When this research is completed, we will have protocols and data supporting the use of these vaccines in further studies in higher animal models leading to human trials as the data warrant.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8720", "attributes": { "award_id": "6U01IP001160-01M003", "title": "Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2021-09-01", "end_date": "2024-08-31", "award_amount": 175000, "principal_investigator": { "id": 24504, "first_name": "Cheryl", "last_name": "Cohen", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1742, "ror": "https://ror.org/00znvbk37", "name": "National Health Laboratory Service", "address": "", "city": "", "state": "", "zip": "", "country": "SOUTH AFRICA", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1742, "ror": "https://ror.org/00znvbk37", "name": "National Health Laboratory Service", "address": "", "city": "", "state": "", "zip": "", "country": "SOUTH AFRICA", "approved": true }, "abstract": null, "keywords": [], "approved": true } }, { "type": "Grant", "id": "8721", "attributes": { "award_id": "1U01IP001160-01", "title": "Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2021-09-01", "end_date": "2026-08-31", "award_amount": 1100000, "principal_investigator": { "id": 24504, "first_name": "Cheryl", "last_name": "Cohen", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1742, "ror": "https://ror.org/00znvbk37", "name": "National Health Laboratory Service", "address": "", "city": "", "state": "", "zip": "", "country": "SOUTH AFRICA", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1742, "ror": "https://ror.org/00znvbk37", "name": "National Health Laboratory Service", "address": "", "city": "", "state": "", "zip": "", "country": "SOUTH AFRICA", "approved": true }, "abstract": "This project aims to generate a body of data that will assist in formulating appropriate policies for the reduction of morbidity and mortality associated with influenza Coronavirus 2019 (COVID-19) and other respiratory pathogens in South Africa. Specifically we aim to perform influenza virus hemagglutination inhibition (HI) testing of serum samples already collected from PHIRST-C participants in a rural and an urban site and from HUTS participants in 2 key communities before and after the 2021 influenza season to determine rates of recent influenza infection. We also aim to characterize healthcare seeking behavior for respiratory illness during the influenza season in the year following the South African COVID-19 epidemic first and second waves through a survey conducted following the influenza season and compare healthcare seeking behavior for respiratory illness to a survey conducted before the 2021 influenza season and assess the impact of different factors on healthcare seeking behavior. We aim to describe the prevalence of MTB-SARS-CoV-2 coinfection and the impact of coinfection on clinical presentation and outcomes in patients presenting with ILI or suspected COVID-19 at ILI surveillance sites or patients admitted with SRI at pneumonia surveillance sites in South Africa. We aim to pilot the implementation of laboratory-confirmed influenza surveillance among individuals participating to the CoughWatchSA participatory digital surveillance platform, compare influenza virus circulation as detected in facility-based surveillance and through the CoughWatchSA platform and to evaluate concordance between self-reported ARI on the CoughWatchSA platform and laboratory-confirmed infection with influenza. This will be achieved through testing of collected serum samples for the presence of anti-influenza antibodies using HI assay, performing a survey of healthcare utilization and serosurvey at two sites in South Africa and implementation of systematic Mycobacterium tuberculosis testing of all participants enrolled in existing pneumonia and influenza-like illness surveillance programmes. Lastly we will pilot self- swabbing of individuals participating in the Coughwatch app for syndromic influenza surveillance.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8726", "attributes": { "award_id": "1U01FD007452-01", "title": "Ga. Dept. of Agriculture - NARMS", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 24507, "first_name": "Claudine", "last_name": "Kabera", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-09-01", "end_date": "2025-08-31", "award_amount": 182000, "principal_investigator": { "id": 24508, "first_name": "Carrie", "last_name": "Crabtree", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 1743, "ror": "", "name": "GEORGIA STATE DEPARTMENT OF AGRICULTURE", "address": "", "city": "", "state": "GA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 1743, "ror": "", "name": "GEORGIA STATE DEPARTMENT OF AGRICULTURE", "address": "", "city": "", "state": "GA", "zip": "", "country": "United States", "approved": true }, "abstract": "NARMS - Project Summary/Abstract The Georgia Department of Agriculture (GDA) is the state agency responsible for regulation of food manufactured facilities and retail establishments. GDA Laboratories (Lab) are the primary servicing laboratories for the regulatory programs and are focused on food analysis for chemical and microbiological contaminants. Since 2011, GDA has pursued FDA grants and cooperative agreements to improve and harmonize our state regulatory and testing capability. Through these grants the Lab achieved accreditation to ISO 17025 international standards which allows our regulatory agencies to perform contractual work on behalf of FDA. Since GDA is Georgia’s regulatory authority over food retail establishments, the agency has inspectors positioned all throughout The State of Georgia. These inspectors are trained to collect samples and return them to our lab for testing that can support regulatory enforcement. Since GDA already has infrastructure designated for sample collection at retail establishments and the analysis of microorganisms by the Lab, this award opportunity NARMS (National Antimicrobial Resistance Monitory System) should make a good fit to be implemented by GDA. The Georgia Department of Public Health (GDPH) Laboratory is currently awarded this grant but has contacted GDA to request assistance or taking it over since the COVID 19 pandemic has become their top priority. In summary, GDA inspectors will collect the samples and send them to the Lab per routine protocols. The Lab will screen the samples for the target organisms suggested in the Funding Opportunity Award (FOA). The Lab will utilize methods described in the project protocol in addition to screening by approved and validated ELISA or PCR platforms. Isolates showing typical characteristics will be further examined and confirmed or sent to FDA for further evaluation. As needed, GDPH has agreed to also assist in in Whole Genome Sequencing of the isolates, since GDA does not currently have that ability, in addition to mentoring of the methods and program until fully established. The Lab has developed and demonstrated successful relationships with their regulatory partners and the GDPH Lab, which should indicate its ability to fulfill this objective. The Lab also routinely performs thousands of microbiological analyses on retail food samples annually. If awarded, GDA will be capable of enhancing and strengthening antimicrobial resistance surveillance data. This in turn can be used to inform public health stakeholders about populations of resistant strains and if current policy and practices are adequate for overall safety of consumers.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "8737", "attributes": { "award_id": "1U19OH012297-01", "title": "Johns Hopkins P.O.E. Total Worker Health Center in Mental Health (POE Center)", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [ { "id": 24486, "first_name": "Maria", "last_name": "Lioce", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-09-01", "end_date": "2026-08-31", "award_amount": 1399623, "principal_investigator": { "id": 24525, "first_name": "Meghan F.", "last_name": "Davis", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 344, "ror": "https://ror.org/00za53h95", "name": "Johns Hopkins University", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 24222, "first_name": "M Daniele", "last_name": "Fallin", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 344, "ror": "https://ror.org/00za53h95", "name": "Johns Hopkins University", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true } ] } ], "awardee_organization": { "id": 344, "ror": "https://ror.org/00za53h95", "name": "Johns Hopkins University", "address": "", "city": "", "state": "MD", "zip": "", "country": "United States", "approved": true }, "abstract": "The overarching goal of the proposed Johns Hopkins P.O.E. Total Worker Health Center in Mental Health (POE Center) is to promote worker mental health and well-being through research, education, outreach and evaluation activities that integrate the psychosocial, organizational, and environmental contexts of worker health. Given the rapid evolution of who works, how they work, and where they work— changes that have accelerated given employer and governmental response to the COVID-19 pandemic—the workforce and workplace are being transformed in ways that will have lasting consequences post-pandemic. Since a large proportion of human life is spent at work, workplace exposures (including psychosocial) are an important contribution to population health or illness. This supports the critical need to not only identify how large-scale disruptions like the COVID-19 pandemic will modify the workforce and workplace in relation to worker mental health, substance use and well-being outcomes, but also to identify and empower resilient systems for health protection and health promotion to maintain workforce functions, health, and well-being before, during and after crises. We will address the following aims: 1) To create a NIOSH Total Worker Health® center that serves the National Occupational Research Agenda (NORA) in Total Worker Health® (TWH) with intentional focus and resources on mental health and substance use prevention and treatment among workers; 2) Integrate concepts of psychosocial, personal, organizational, and environmental context into TWH monitoring and evaluation; and 3) To evaluate POE Center activities in outreach, training, dissemination, and research, and to support the overall goals of the POE Center and NIOSH TWH program. Given the special issues related to mental and behavioral health, including the alarming frequency of problems, the very real barriers due to stigma and privacy concerns, and the hidden costs due to presenteeism versus absenteeism, a NIOSH Total Worker Health center specifically dedicated to worker mental health is greatly needed.", "keywords": [], "approved": true } } ], "meta": { "pagination": { "page": 1385, "pages": 1421, "count": 14208 } } }